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Abstract
Background: The presence of four mammalian cell entry (mce) operons in Mycobacterium tuberculosis suggests the
essentiality of the functions of the genes in these operons. The differential expression of the four mce operons in
different phases of in vitro growth and in infected animals reported earlier from our laboratory further justifies the
apparent redundancy for these genes in the genome.
Here we investigate the extent of polymorphism in eight genes in the mce1 and mce4 operons of M. tuberculosis
from four standard reference strains (H37Rv, H37Ra, LVS (Low Virulent Strain) and BCG) and 112 clinical isolates
varying in their drug susceptibility profile, analysed by direct sequencing and Sequenom MassARRAY platform.
Results: We discovered 20 single nucleotide polymorphisms (SNPs) in the two operons. The comparative analysis of
the genes of mce1 and mce4 operons revealed that yrbE1A [Rv0167] was most polymorphic in mce1 operon while
yrbE4A [Rv3501c]a n dlprN [Rv3495c] had the highest number of SNPs in the mce4 operon. Of 20 SNPs, 12 were found to
be nonsynonymous and were further analysed for their pathological relevance to M. tuberculosis using web servers
PolyPhen and PMut, which predicted five deleterious nonsynonymous SNPs. A mutation from proline to serine at
position 359 of the native Mce1A protein was most deleterious as predicted by both PolyPhen and PMut servers.
Energy minimization of the structure of native Mce1A protein and mutated protein was performed using InsightII. The
mutated Mce1A protein showed structural changes that could account for the effects of this mutation.
Conclusions: Our results show that SNPs in the coding sequences of mce1 and mce4 operons in clinical isolates
can be significantly high. Moreover, mce4 operon is significantly more polymorphic than mce1 operon (p < 0.001).
However, the frequency of nonsynonymous substitutions is higher in mce1 operon and synonymous substitutions
are more in mce4 operon. In silico modeling predict that nonsynonymous SNP at mce1A [Rv0169], a virulence gene
could play a pivotal role in causing functional changes in M. tuberculosis that may reflect upon the biology of the
bacteria.
Background
The variability in the genome sequence of M. tuberculosis
between clinical isolates has been analysed earlier and varia-
bility in the number and site of integration of transposable
element IS6110 is well documented [1]. There are also
reports on the analysis of whole genome SNPs in
mycobacteria [2]. Compared to many other bacterial spe-
cies, M. tuberculosis exhibits very little genomic sequence
variation [3]. However, there is increasing evidence that
even this limited inter-strain genetic variability is biologi-
cally significant [4]. M. tuberculosis infection in animal
models has shown a range of immune responses and vari-
able degrees of virulence depending on the infecting strain
[5,6]. In the majority of humans, an effective immune
response develops after infection with M. tuberculosis and
restricts the spread of the pathogen and clinical
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any medium, provided the original work is properly cited.manifestation of the disease is seen in less than 10% of
those infected. Clinical tuberculosis is influenced by varia-
bility in the host’s genetic background, immune status, diet,
social and environmental factors [7,8]. However, little is
known about the bacterial factors, especially, genetic diver-
sity in bacterial virulence factors contributing to variable
host responses.
The expression of mce genes is of importance for the
v i r u l e n c eo fm y c o b a c t e r i a[ 9 , 1 0 ] .T h ep r e s e n c eo ff o u r
copies of mce genes in four operons each consisting of
eight genes [11] and the differential expression of mce1
and mce4 operons points towards functional importance
of these operons [9,12]. Interestingly, the domain orga-
nization in the genes of all the four operons is similar.
This conservative arrangement may be of strategic sig-
nificance to the biology of M. tuberculosis. The antigenic
and immunogenic effects of mce proteins in nature sug-
gest that the variation in amino acid sequence of these
proteins may affect host response, apart from their effect
on functions of these proteins [13,14]. In the light of
these observations, we initiated the present study to
understand the possible importance of genetic diversity
in the mce operon genes which have a role in the patho-
genesis of M. tuberculosis. Polymorphism in the genes of
mce1 and mce4 operons in 112 clinical isolates of
M. tuberculosis was analysed to understand and relate
the effect of the genetic variability to structural changes
in the proteins by computational methods.
Results
Single nucleotide polymorphism in mce operons
We used a discovery platform consisting of four standard
reference strains (H37Rv, H37Ra, LVS (Low Virulent
Strain) and BCG) and 12 clinical isolates selected at ran-
dom. Overlapping primers were designed to map eight
genes each of mce1 and mce4 operons (Figure 1). We iden-
tified 7 SNPs in mce1 operon; 6 of these were nonsynon-
ymous and one was synonymous substitution (Table 1).
100 clinical isolates were then genotyped for these SNPs
on Sequenom MassARRAY platform. Among 8 genes of
mce1 operon, yrbE1A [Rv0167] gene was significantly more
polymorphic as compared to the other seven genes, with
approximately 26% of clinical isolates showing the poly-
morphic allele. In comparison 13 SNPs were identified in
mce4 operon (Table 2), of which 6 were nonsynonymous
and 7 were synonymous SNPs. In mce4 operon significant
polymorphism was observed in clinical isolates at yrbE4A
[Rv3501c]a n dlprN [Rv3495c] genes with 25.50% and
26.50% SNP respectively.
Effect of SNPs on codon usage in mce operons
The preferential usage of codons for different amino
acids in various organisms including M. tuberculosis is
well known. The codon bias influences the translational
efficiency in these organisms [15]. Therefore, we analysed
the codon usage in M. tuberculosis for synonymous
changes observed in both mce1 and mce4 operons. Ana-
lysis revealed that codons of amino acids were changed
to the next preferred codon (Table 3). It is possible that
such altered preference for certain codons would alter
the expression of the respective proteins.
Prediction of functional consequences of nonsynonymous
SNPs by PolyPhen and PMut servers
The functional impact of 12 nonsynonymous SNPs in
proteins of mce1and mce4 operons was analyzed using
PolyPhen http://genetics.bwh.harvard.edu/pph/ and
PMut http://mmb2.pcb.ub.es:8080/PMut/ servers. Of the
12 nonsynonymous SNPs studied, 5 nonsynonymous
SNPs were predicted to be deleterious to the organism
by both PolyPhen and PMut programs. These nonsy-
nonymous SNPs were located in the genes yrbE1B
[Rv0168] (NN output; 0.84, PSIC score; 1.6), mce1A
[Rv0169] (NN output; 0.84, PSIC score; 2.04), mce1B
[Rv0170] (NN output; 0.59, PSIC score; 1.6), lprN
[Rv3495c] (NNoutput; 0.55, PSIC score; 1.73) and mce4F
[Rv3494c] (NN output; 0.52, PSIC score; 2.01). Whereas
the other 7 nonsynonymous SNPs had NN output < 0.5
and PSIC score < 1.5. The highest score in this analysis
was for mce1A gene with C1075T mutation resulting in
substitution of proline to serine at 359 amino acid posi-
tion. Thus, C1075T was considered to be the most dele-
terious mutation by PolyPhen and PMut programs.
Modeling of mutated protein structure
We selected C1075T (Pro359Ser) polymorphism in mce1A
g e n ea ss h o w ni nT a b l e1f o rf u r t h e rs t r u c t u r a la n a l y s i s .
The substitution is positioned at 359 amino acid and we
have mapped this in the three dimensional structure
[PDB: 1NA9] [16]. Mutation at the specified position was
performed by InsightII/Biopolymer and energy minimiza-
tions were performed by InsightII/Discover module for
both the native structure [PDB: 1NA9] and mutant mod-
eled structure (Pro359Ser). This structural analysis shows
that the native (Figure 2A) and the mutant (Figure 2B)
protein structure has an RMSD of 3.07 Ǻ. It is interesting
t oo b s e r v et h a t ,i nt h en a t i v es t r u c t u r e ,P r o l i n e 3 5 9i sa
part of the helical conformation while the mutated coun-
terpart (Pro359Ser) has a loop structure at this position
(Figure 3). Perturbation in the hydrogen bonds as
indicated in the HB plots (Figure 4A and 4B) could be
attributed to the conformational changes at Ser 359
position and other regions of mutant protein.
Correlation between drug resistance and SNPs
Approximately 59 drug resistant (DR) and 22 drug sen-
sitive (DS) clinical isolates were analysed further. Four
first line drugs namely isoniazid, rifampicin, ethambutol
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Page 2 of 11and streptomycin were taken into account to character-
ize the isolates. The sensitive isolates were sensitive to
all the four antitubercular drugs while the resistant iso-
lates were resistant to atleast one drug. The comparison
between the two categories revealed that mce1 and mce4
operon genes were significantly more polymorphic in
DS clinical isolates than DR isolates (*, p < 0.05) (Figure
5A) and (**, p < 0.01) (Figure 5B) respectively.
Among 59 DR clinical isolates, 19 were MDR TB
(Multi drug resistant, at least to isoniazid and rifampi-
cin). Among 19 MDR TB clinical isolates, polymorphism
was observed in yrbE1A (15.78%) and yrbE1B (5.26%)
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Figure 1 Primers of mce operons. Schematic representation of the position of overlapping primers to completely sequence the genes of (A)
mce1 operon (B) mce4 operon.
Table 1 Polymorphisms in the genes of mce1 operon
mce1 operon
Gene Name
(Accession Number)
Nucleotide Change
[GenBank Accession Number]
Amino Acid Change Frequency Distribution of polymorphism
(%)
Non Synonymous Synonymous All isolates
n = 112
DS
n=2 2
DR
n=5 9
SDR
n=1 5
MDR TB
n=1 9
yrbE1A
[Rv0167]
C14T
[GenBank:HQ901088]
Thr5Ile NONE (25.96) (29.16) (29.09) (41.76) (15.78)
yrbE1B
[Rv0168]
T154G
[GenBank:HQ901089]
Tyr52Asp NONE (0.9) NONE (1.72) NONE (5.26)
mce1A
[Rv0169]
C1075T
C1323T
[GenBank:HQ901082]
Pr0359Ser Tyr441Tyr (1.87) (4) NONE NONE NONE
mce1B
[Rv0170]
T536C
[GenBank:HQ901085]
Ile179Thr NONE (0.9) (3.8) NONE NONE NONE
mce1C
[Rv0171]
G636C
[GenBank: HQ901086]
Glu212Asp NONE (0.9) (3.8) NONE NONE NONE
mce1D
[Rv0172]
NONE NONE NONE NONE NONE NONE NONE NONE
lprK
[Rv0173]
NONE NONE NONE NONE NONE NONE NONE NONE
mce1F
[Rv0174]
G129T
[GenBank: HQ901083]
Lys43Asn NONE (0.9) (4) NONE NONE NONE
Frequency of single nucleotide polymorphisms detected in the genes of mce1 operon. The nucleotide changes and the corresponding changes in amino acids
are shown here. The frequency of SNPs was calculated from 112 clinical isolates. The data has been subdivided according to the drug susceptibility profile.
The single letter nucleotide designations used are as follows: A, adenine; C, cytosine; G, guanine and T, thymidine. The three letter amino acid designations used
are as follows: Thr, threonine; Ile, isoleucine; Tyr, tyrosine; Asp, aspartic acid; Pro, proline; Ser, serine; Glu, glutamic acid; Lys, lysine and Asn, asparagine.
DS: drug sensitive, DR: drug resistant, SDR: single drug resistant, MDR TB: Multi drug resistant.
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(5.26%), lprN (31.57%) and mce4F (10.52%) genes of
mce4 operon. Of the 15 single drug resistant (SDR) clin-
ical isolates studied, polymorphism was observed in
yrbE1A (41.76%) gene of mce1 operon and in yrbE4A
(41.76%), yrbE4B (5.88%), mce4C (5.26%), lprN (35.29%)
and mce4F (5.88%) genes of mce4 operon. Interestingly,
mce genes were significantly more polymorphic in SDR
strains than MDR TB strains in both mce1 and mce4
operons. (**, p < 0.01 and ***, p < 0.001 respectively).
Table 2 Polymorphisms in the genes of mce4 operon
mce4 operon
Gene Name
(Accession Number)
Nucleotide Change
[GenBank Accession Number]
Amino Acid Change Frequency Distribution of polymorphism
(%)
Non Synonymous Synonymous All isolates
n = 112
DS
n=2 2
DR
n=5 9
SDR
n=1 5
MDR TB
n=1 9
yrbE4A
[Rv3501c]
G18T
C753A
[GenBank: HQ901084]
NONE Ala6Ala
Ile251Ile
(25.49) (20.83) (29.62) (41.76) (21.05)
yrbE4B
[Rv3500c]
C21T
C624T
[GenBank: HQ901090]
NONE Ile7Ile
Pro208Pro
(3.7) (8) (3.44) (5.88) NONE
mce4A
[Rv3499c]
T32G
C873T
[GenBank: HQ901091]
Val11Gly Phe291Phe (2.25) (4.55) NONE NONE NONE
mce4B
[Rv3498c]
NONE NONE NONE NONE NONE NONE NONE NONE
mce4C
[Rv3497c]
A136C
C571A
[GenBank: HQ901092]
Thr46Pro
Arg191Ser
NONE (3.75) (8.33) NONE (5.88) (5.26)
mce4D
[Rv3496c]
G35A
[GenBank: HQ901093]
Arg12Gln NONE (1.25) (7.69) NONE NONE NONE
lprN
[Rv3495c]
C798T
C1016A
[GenBank: HQ901094]
Thr339Lys Ala266Ala (26.47) (29.09) (30.9) (31.57) (31.07)
mce4F
[Rv3494c]
C117A
C1214T
[GenBank: HQ901087]
Pro405Lys Thr39Thr (8.75) (9.09) (7.3) (10.52) (5.09)
Frequency of single nucleotide polymorphisms detected in the genes of mce4 operon. The nucleotide changes and the corresponding changes in amino acids
are shown here. The frequency of SNPs was calculated from 112 clinical isolates. The data has been subdivided according to the drug susceptibility profile.
The single letter nucleotide designations used are as follows: A, adenine; C, cytosine; G, guanine and T, thymidine. The three letter amino acid designations used
are as follows Ala, alanine; Ile, isoleucine; Pro, proline; Val, valine; Gly, glycine; Phe, phenylalanine; Thr, threonine; Arg, arginine; Ser; serine; Gln, glutamine and
Lys, lysine.
DS: drug sensitive, DR: drug resistant, SDR: single drug resistant, MDR TB: Multi drug resistant.
Table 3 Codon usage in mce1 and mce4 operons
Operon Gene name (Accession Number) Wild type codon Polymorphic codon
mce1 operon mce1A
[Rv0169]
TAC TAT
yrbE4A
[Rv3501c]
GCG
ATC
GCT
ATA
mce4 yrbE4B
[Rv3500c]
ATC
CCC
ATT
CCT
operon mce4A
[Rv3499c]
TTC TTT
lprN
[Rv3495c]
GCC GCT
mce4F
[Rv3494c]
ACC ACA
The codon usage in the polymorphic regions is shown here. The synonymous changes in the nucleotide sequence, when analysed bioinformatically through
Gene Runner software version 3.05 (Hastings Software, Inc.) predicts the usage of less preferred codon which could reflect upon the expression efficiency of the
protein encoded by the gene.
Nucleotide highlighted in bold indicates the altered nucleotide.
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(B)
Figure 2 Wild and mutant protein structure of Mce1A. Structure of (A) wild (orange ribbon) and (B) Pro359Ser mutant (blue ribbon) proteins
showing Pro359 (green) in wild protein and Ser359 (pink) in the mutant protein represented in ball and stick. The figure was prepared using
Discovery studio 2.5 (DS Modeling 2.5, Accelrys Inc.: San Diego, CA).
Figure 3 Comparison of Wild and mutant protein structure of Mce1A. Superimposed structure of wild (orange) and Pro359Ser mutant
(blue) of Mce1A protein showing a change in helix to loop conformation after energy minimization of protein structures, as described in
methods section. The RMSD between native and mutant protein was 3.07Ǻ. Pro359 (green) in wild protein and Ser359 (pink) in the mutant
protein are represented in ball and stick.
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It has been observed that severity of tuberculosis varies
in different patients. It is possible that clinical isolates of
M. tuberculosis encountering the human hosts with indi-
vidual immune systems need to accordingly modulate
their virulence associated biological factors to survive
within the host. Therefore, it is important to understand
the biology of the pathogen at the genetic level. Genetic
polymorphisms in the bacterial hosts have been shown
to significantly influence the biology of the organisms
[17]. In M. tuberculosis, most of the polymorphisms
have been studied in the transposable elements and
drug resistant genes [1,18]. A study of the genetic muta-
t i o n si nt h eg e n e sc o d i n gf o rv i rulence factors interact-
ing with host’s immune system would help us in
understanding the ways in which various strains of
M. tuberculosis adapt to different hosts.
The sequencing and Sequenom MassARRAY analysis
presented here have revealed that mce4 operon is signif-
icantly more polymorphic than mce1 operon. Seven out
of eight genes of mce4 operon were found to be poly-
morphic. The mce4 operon is expressed in the stationary
phase of in vitro broth culture and in the late phase of
infection [9,12] and has role in the survival of the patho-
gen inside the host body [19]. This is the time when the
bacterium has established itself efficiently in the host
a n di ti sp o s s i b l et h a tt h eb a c t e r i u mt h e np e r m i t si t s e l f
to undergo genetic substitutions to evade the host
immune response. The detailed analysis of codon usage
for synonymous changes observed in both mce1 and
mce4 operons revealed that codons of amino acids were
changed to the next preferred codon which would alter
the expression of proteins. Our observation of more
codon bias in mce4 operon that may lead to less expres-
sion of proteins further supports the possibility that such
diversity facilitates better survival of M. tuberculosis
inside the host’s body. Our results further reveal that
more than 25% of clinical isolates have SNPs in yrbE4A
and lprN genes of mce4 operon. The lprN gene of mce4
operon codes for lipoprotein precursor [20]. The lipopro-
teins of M. tuberculosis are known to be effectively anti-
g e n i ci nn a t u r e[ 2 1 ] .T h u s ,h i g hp o l y m o r p h i s mi nlprN
gene (both synonymous and nonsynonymous) further
supports our hypothesis that such polymorphisms favour
intracellular survival of the pathogen. Drug resistance
itself makes the organism in a better position to survive
within the hostile intracellular environment. But DS iso-
lates being drug susceptible do not have this advantage.
Therefore antigenic variation is a tool utilized by DS clin-
ical isolates. For example, the function of PPE proteins is
unknown. However several observations and results sup-
port that many are cell surface associated and recognized
 
	
 	

Figure 4 HB plot representation of wild and mutant Mce1A protein. HB plot of wild (A) and Pro359Ser mutant (B) Mce1A protein. Break in
the diagonal at position 359 in the HB plot of Pro359Ser indicates loss of hydrogen bond after mutation. Conformational changes in other
regions could be attributed to the alteration of hydrogen bonds in these regions. Colours of the dots in the HB plot indicated the type of
hydrogen bond interactions: side chain-side chain (blue), main chain-main chain (orange), main chain-side chain (red) and multiple hydrogen
bonds between amino acid residues (pink) The figures were prepared using Discovery studio 2.5 (DS Modeling 2.5, Accelrys Inc.: San Diego, CA).
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Page 6 of 11by the host immune system. The possibility of high anti-
genic variation associated with these highly antigenic PE
and the PPE family proteins have also been reported [22].
The PGRS member Rv1759 is a fibronectin-binding pro-
tein of relative molecular mass 55,000 Da [23] that elicits
a variable antibody response, indicating either that indivi-
duals mount different immune responses or that this
PGRS protein may vary between strains of M. tuberculo-
sis. Bioinformatics analysis have indicated that LprN is
also a cell surface associated protein. Therefore it is
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Figure 5 Comparative analysis of the frequency of SNPs in the mce operons genes of drug resistant (DR) and drug sensitive (DS)
clinical isolates. SNPs were explored using Sequenom MassARRAY platform. DR (n = 59) and DS (n = 22) clinical isolates of M. tuberculosis were
taken up for this study. The comparison between the two categories revealed that (A) mce1 and (B) mce4 operon genes were significantly more
polymorphic in DS clinical isolates than DR isolates (*, p < 0.05) and (**, p < 0.01) respectively.
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lated into antigenic variation in the LprN protein to facil-
itate the intracellular survival of mycobacteria.
In contrast, the mce1 operon is required for the entry
of the pathogen inside the host cell [24] and hence,
remains less polymorphic. However, the yrbE1A gene is
revealed to be highly polymorphic in mce1 operon.
Since, YrbE1A has been predicted to be a transmem-
brane protein [20], so the observed polymorphism in its
gene may influence activity of the protein.
From the computational analysis, we could infer that
the results obtained on the basis of structural details
(PolyPhen) and sequence details (PMut) were in tune
with each other. Both the programs have predicted that
the SNP observed in mce1A gene is having the highest
pathological relevance. Although, programs used here
were primarily designed for predicting functional conse-
quences of nonsynonymous SNPs in human proteins.
However, concurrent observations on the nonsynon-
y m o u sS N P so fmce operon proteins reported by both
PolyPhen and PMut substantiate our hypothesis further.
Energy minimization studies on the structure of Mce1A
protein show that Pro359Ser mutation resulted in the
loss of a-helical structure in the mutated protein. Analy-
sis of wild and mutated Mce1A protein structures by
HB plot indicates that change in hydrogen bonding
interaction pattern in the mutant protein lead to confor-
mational changes. Mutation of proline to serine residue
in proteins are known to cause structural alterations by
the reduction of a-helix content of protein and
decreases protein stability and increase its susceptibility
to proteolysis by trypsin [25]. Yazyu et al. [26] observed
that Pro122Ser mutation could bring about the altera-
tion in the pH of the system by changing the cation spe-
cificity of melibose carrier (a membrane bound protein
which mediates co transport of a-galactosides with
monovalent cations) in E. coli. Pro122Ser mutant lost
the ability to utilize H
+ and made the carrier favorable
for Li
+- melibose co-transport. Serine being a hard
Lewis base interacts with hard Lewis acids such as Li
+
instead of H
+ [26]. Mce1A protein is a cell surface pro-
tein [27] so it may be speculated that the aforemen-
tioned changes due to Pro359Ser mutation may have a
diminishing effect on the stability of protein and thus
on the biological function of it.
In a further analysis, we compared the SNPs in the
genes of mce1 and mce4 operons in 59 drug resistant
(DR) and 22 drug sensitive (DS) clinical isolates. The
comparison of SNPs in the mce genes in DR and DS
clinical isolates revealed that both mce1 and mce4
operon genes of DS clinical isolates were more poly-
morphic than DR clinical isolates. It is possible that
while drug resistance provides extra edge to DR isolates,
the DS isolates try to enhance their virulence mechan-
isms and adaptability to hostile intracellular environ-
ment by undergoing mutations in them. This is also
supported by a report by Shimono et al. [28] where they
have demonstrated that, unlike wild type M. tuberculo-
sis,as t r a i no fM. tuberculosis with disrupted mce1
operon become hypervirulent.
Further study of larger number of single and multi
drug resistant isolates may give a conclusive answer to
the significance of such an observation.
Taken together the SNP analysis and in silico modeling
reported here predict that the SNPs in the mce1 and mce4
operons in the clinical isolates are reasonably frequent.
Also, the in silico modeling of nonsynonymous SNP in the
mce1A gene of mce1 operon indicates that such change
may translate into altered function of the gene that may
reflect on the virulence and biology of the pathogen.
Conclusions
In the present study, we have investigated the extent of
polymorphism in the genes of mce1 and mce4 operons of
M. tuberculosis in a panel of four standard reference strains
(H37Rv, H37Ra, LVS (Low virulent Strain) and BCG) and
112 clinical isolates. Our results show that SNPs in the cod-
ing sequences of mce1 and mce4 operons in clinical isolates
can be significantly high. Twenty SNPs were discovered in
the two operons out of which 12 were nonsynonymous
changes. Further analysis of pathological relevance of these
changes revealed that five of the SNPs were deleterious.
Overall, mce4 operon is significantly more polymorphic
than mce1 operon (p < 0.001). However, nonsynonymous
SNPs detected in mce1A gene of mce1 operon predict effect
of such SNPs on the biology of the pathogen.
Methods
Bacterial Strains
A collection of ~112 M. tuberculosis clinical isolates and
four standard refrence strains (H37Rv, H37Ra, LVS
(Low virulent Strain) and BCG) were taken for the
study. These isolates were from the patients visiting the
out patient department (OPD) of Vallabhbhai Patel
Chest Institute, Delhi, India. The strains were collected
from sputum samples submitted to the Department of
Microbiology for laboratory diagnosis of tuberculosis.
The study was approved by the institutional ethics com-
mittee. Informed consent was also signed by the patients
included in the study.
Processing of the sample
The sputum samples were decontaminated by the stan-
dard Petroff’s method [29] and inoculated on Lowen-
stein Jensen (LJ) media. DNA was extracted from the
cultures by the CTAB method [30]
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Drug susceptibility testing was performed by the propor-
tion method. The drug concentrations tested as per
WHO recommendations were 0.2 mg/litre for isoniazid,
40 mg/litre for rifampicin, 2 mg/litre for ethambutol
and 4 mg/litre for streptomycin. The drug incorporated
LJ slants were incubated at 37°C and observed at 28 and
42 days of incubation [31]. The drug susceptibility was
carried out on 59 DR and in 22 DS isolates out of the
100 clinical isolates and in 12 random selected isolates.
PCR amplication
Sixteen genes of mce1 and mce4 operons were amplified
using overlapping primers listed in Additional file 1 for
4 standard refrence strains (H37Rv, H37Ra, LVS (Low
Virulent Strain) and BCG) and 12 clinical isolates. Ther-
mal cycling was carried out for 40 cycles, with initial
denaturation at 95°C for 10 minutes, followed by dena-
turation at 94°C for 1 minute, annealing at 56°C-64°C
for 1 minute depending on primer sequence, elongation
at 72°C for 1 minute and a final extension of 72°C for
10 minutes. The amplicons were purified by Qiagen
PCR purification kit to remove unincorporated nucleo-
tides and dNTPs.
Sequencing and Data Analysis
The PCR products obtained by using the overlapping
primer sets as described above from four standard refer-
ence strains (H37Rv, H37Ra, LVS (Low Virulent Strain)
and BCG) and 12 clinical isolates were sequenced using
a DNA sequencer 3730 (Applied Biosystems). Both
strands were sequenced to confirm the sequence data.
The sequences were aligned and compared with the
reference sequence of H37Rv available in public domain
at Tuberculist http://genolist.pasteur.fr/TubercuList/[11]
using Align two sequences (bl2seq) of BLAST http://
blast.ncbi.nlm.nih.gov/Blast.cgi [32]. The SNPs obtained
by the sequence analysis were used to screen other 100
clinical isolates through Sequenom MassARRAY system.
All the SNPs were analysed further for the change in
amino acids in the corresponding protein sequences
through Gene Runner software version 3.05 (Hastings
Software, Inc.) available at http://www.generunner.net.
Computational methods
Structure homology-based method (PolyPhen) to predict
functional and structural changes in proteins
In order to analyze the impact of nonsynonymous SNPs
on the structure and function of proteins of mce oper-
ons, Polyphen server http://genetics.bwh.harvard.edu/
pph/[33] was used. Protein sequences in FASTA format
with the position of amino acid variants indicated were
submitted as the query. Polyphen server calculates posi-
tion- specific independent counts (PSIC) scores for each
of the two variants based on the parameters such as
sequence-based characterization of the substitution site,
profile analysis of homologous sequences, and mapping
of the substitution site to a known protein’st h r e e
dimensional structure and then the difference between
the PSIC scores of the two variants are computed. The
higher the PSIC score (> 1.5) difference, the higher the
functional impact a particular amino acid substitution is
likely to have.
Neural network-based sequence information method
(PMut) to predict pathological character of
nonsynonymous SNPs
PMut server http://mmb2.pcb.ub.es:8080/PMut/[34] was
used to predict pathological relevance of nonsynon-
y m o u sS N P si nt h emce operon proteins. The software
uses different kinds of sequence information to label
mutations from the databases of disease-associated
mutations (DAMU), and neural networks (NNs) to pro-
cess the databases of DAMUs and neutral mutations
(NEMUs). The resulting vector of properties is then uti-
lized to decide whether the mutation is pathological or
not. Although, PMut is designed to analyze pathological
character associated with mutations in the human pro-
teins. A number of workers [35,36] have qualitatively
interpreted the functionality of mutated non-human
proteins especially that of microbes. We submitted the
protein sequences as the query, the location of the
mutation and the amino acid residues were also furn-
ished. Small NN (20 nodes, 1 hidden layer) with using
2/3 input parameters (pam40 matrix index, pssm index,
variability index) was used to train the database as it is
recommended for predictions of non-human proteins
[34]. NN output greater than 0.5 is predicted as patholo-
gical otherwise neutral.
Molecular Modeling of nonsynonymous SNP located on
the protein structure
The homology modeled three dimensional structure of
Mce1A protein submitted to protein databank [PDB:
1NA9] [16] was used to study the effect of mutated resi-
due. The authors have modelled Mce1A structure from
residues 68 to 376, the N-terminal 67 residues and the
C-terminal 78 residues were not modelled due to lack of
homology [16]. Biopolymer module implemented in
InsightII (Accelrys Inc.: San Diego, CA) was used to
modify the mutated residues, from the InsightII frag-
ment library. Using the same module, hydrogen atoms
were added to both wild type and mutated protein
structures at pH 7.0. The default cvff (Consistent
Valence Force Field) force field [37] was applied to both
the structures. Further, a series of energy minimization
steps were performed on both the protein structures by
InsightII/Discover (Accelrys Inc., San Diego, CA) using
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tion, all the heavy (all non-hydrogen) atoms were con-
strained, the hydrogen atoms were allowed to minimize
by steepest decent algorithm until the maximum deriva-
tive (|dE/dr|) of the system was <1 kcal/(mole.Ǻ).
(b) This step was followed by another steepest descent
minimization with the same parameter as in step (a),
but constraining the protein backbone atoms and relax-
ing all other atoms of the molecule. (c) In the final step,
the protein molecule was minimized by conjugate gradi-
ent method with the backbone atom fixed and allowing
all other atoms relax until the maximum derivative was
<0.01 kcal/(mole.Ǻ). The deviation between the two
structures is evaluated by their RMSD values which
could affect stability and functional activity. Structure
analysis of protein after energy minimization of protein
structure was analyzed using Discovery Studio 2.5 (DS
Modeling 2.5, Accelrys Inc.: San Diego, CA).
Statistical methods
Statistical analysis was done by Fischer’s exact t test
using Graph Pad Prism software http://www.graphpad.
com/quickcalcs/contingency1.cfm. A two-tailed p-value
< 0.05 was considered statistically significant.
Additional material
Additional file 1: Overlapping primers to sequence entire mce1 and
mce4 operons.
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